The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Ulipristal Acetate Rowex 30 mg Film-coated Tablets

Rowex LtdPA0711/292/001

Main Information

Trade NameUlipristal Acetate Rowex 30 mg Film-coated Tablets
Active SubstancesUlipristal acetate
Dosage FormFilm-coated tablet
Licence HolderRowex Ltd
Licence NumberPA0711/292/001

Group Information

ATC CodeG03AD Emergency contraceptives
G03AD02 ulipristal


License statusAuthorised
Licence Issued01/11/2019
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back